Public Company News

New Major Order From China

STOCKHOLM, Sept. 30, 2019 /PRNewswire/ -- Bactiguard has received a new order from Well Lead Medical (Well Lead) inChina. The order will be delivered promptly and generate revenues in the third quarter of approximatelySEK 4,8 million. "The order we have just received from Well Lead is the first ...

2019-09-30 11:45 3791

Forescout Appoints Wahab Yusoff as Regional Vice President for Asia Pacific and Japan

SAN JOSE, Calif., Sept. 30, 2019 /PRNewswire/ -- Forescout Technologies, Inc.  (NASDAQ: FSCT), the leader in device visibility and control, today announced the appointment ofWahab Yusoff to Regional Vice President forAsia Pacific and Japan (APJ). In this role Wahab wil...

2019-09-30 11:00 8255

Phase 3 PRIMA trial of Zejula® (niraparib) is the first study to show a PARP inhibitor significantly improves PFS, regardless of biomarker status, when given as monotherapy in women with first-line platinum responsive advanced ovarian cancer

* The PRIMA study, presented in a Presidential Symposium at the 2019 European Society for Medical Oncology congress and simultaneously published inThe New England Journal of Medicine,demonstrates that niraparib treatment resulted in a 38% reduction in the risk of disease progression or death in...

2019-09-29 12:13 8765
1 ... 819820821822823